[Recommendations for the definition of a policy on vaccination against papillomavirus in Mexico. Strategic Advisory Group of Experts of the World Health Organization].
Lazcano-Ponce
Eduardo
E
Instituto Nacional de Salud Pública, México. elazcano@insp.mx
Salmerón-Castro
Jorge
J
García-Carrancá
Alejandro
A
Aranda-Flores
Carlos
C
Madrid-Marina
Vicente
V
Gómez-Altamirano
César Misael
CM
Martínez-Montañez
Olga Georgina
OG
D000293:Adolescent; D000328:Adult; D052685:Alphapapillomavirus / Q000276:immunology / Q000472:pathogenicity; D002648:Child; D003906:Developing Countries; D004306:Dose-Response Relationship, Immunologic; D005260:Female; D006291:Health Policy; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D007115:Immunization Schedule; D008800:Mexico; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D053918:Papillomavirus Vaccines / Q000008:administration & dosage / Q000276:immunology; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D014611:Vaccination / Q000331:legislation & jurisprudence; D055815:Young Adult
D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines; C510352:human papillomavirus vaccine, L1 type 16, 18